Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Science to Business Network (S2BN) Podcast

Claim This Podcast

by Science to Business Network (S2BN)

5 episodes

Updated Daily

Accepts GuestsHas SponsorsLocation 🇨🇦

Podcast Overview

The S2BN Podcast, hosted by the S2BN's Founder and CEO, Bruce Seet, features conversations with scientists, leaders and individuals who are working at the interface of science, innovation and business. We hear their career journeys, stories, insights and advice that have enabled them to change the world through science and business. The Science to Business Network (S2BN) is a multi-chapter, non-profit organization that aims to promote innovative thinking, professional development, entrepreneurialism and networking among scientists, industry professionals and other stakeholders within the innovation ecosystem. For more information, visit our website at www.s2bn.org.

Language

🇺🇲

Publishing Since

5/8/2020

Visit Website View on Apple Podcasts RSS Feed

2 verified contact emails on file for Science to Business Network (S2BN) Podcast

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

January 13, 2021

Rob Henderson - Developing BioTalent

Rob Henderson, President/CEO of BioTalent Canada, shares his career path, insights and lessons learned. BioTalent Canada is one of Canada's leading organizations engaged in supporting STEM career development, training courses and workshops and experiential learning programs such as the Student Work Placement Program (SWPP).

January 12, 2021

Leah Cowen - Targeting Antifungal Resistance

In this episode, Dr. Leah Cowen shares her journey as a scientist, professor, and academic department chair at the University of Toronto towards her role as an entrepreneur, Chief Scientific Officer and co-founder of Bright Angel Therapeutics, a company that develops novel therapeutics to address the growing global public health crisis of antifungal resistance.

May 8, 2020

Grant McFadden - A Pox on Your Cancer

In this inaugural Science to Business Network (S2BN) podcast, Dr. Grant McFadden shares his scientific journey as well as his experience and lessons learned as an entrepreneur having formed two companies during his career. His latest company, Oncomyx, seeks to deploy an obscure poxvirus of rabbits to save human lives by using this virus to treat cancer. Grant also discusses the implications of the 40th anniversary of the eradication of smallpox (which was announced by the WHO on May 8, 1980) and also shares his perspective on the impact of COVID19 and the work he’s doing to create a SARS-CoV2 vaccine. Grant McFadden, PhD, is a world-renowned poxvirus researcher, Professor at Arizona State University, Director of the Biodesign Center for Immunotherapy, co-Editor-in-Chief of the journal PLoS Pathogens and past President of the American Society for Virology. Having started his career in Canada, his lab pioneered the field of viral immune subversion and is credited with the discovery of a wide spectrum of virus-derived inhibitors of the immune system.

5 total episodes available

Deep-dive analytics for Science to Business Network (S2BN) Podcast

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Science to Business Network (S2BN) Podcast?: The S2BN Podcast, hosted by the S2BN's Founder and CEO, Bruce Seet, features conversations with scientists, leaders and individuals who are working at the interface of science, innovation and business. We hear their career journeys, stories, insights and advice that have enabled them to change the world through science and business.

The Science to Business Network (S2BN) is a multi-chapter, non-profit organization that aims to promote innovative thinking, professional development, entrepreneurialism and networking among scientists, industry professionals and other stakeholders within the innovation ecosystem. For more information, visit our website at www.s2bn.org.
How often does this podcast release new episodes?: This podcast updates daily.
Where can I listen to this podcast?: This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.